E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/12/2018 in the Prospect News Investment Grade Daily.

Morning Commentary: Fairfax, International Development signal deal plans; CVS notes soften

By Cristal Cody

Tupelo, Miss., April 12 – Investment-grade deal action remains light early Thursday, but several issuers are offering bonds.

Fairfax Financial Holdings Ltd. was underway Thursday morning marketing a Rule 144A and Regulation S offering of senior notes to price soon.

Also, the International Development Association (Aaa/AAA) plans an inaugural bond offering in the near-term horizon.

New issuance also is expected to follow roadshows being held by Syngenta AG and Ausgrid Finance Pty Ltd.

Supply has been thin over the week with less than $7 billion of reported high-grade bonds priced. Syndicate sources forecast about $10 billion to as much as $17 billion of volume for the week.

Market sources were focused on upcoming bank and financial earnings releases. On Friday, Citigroup Inc., Wells Fargo & Co. and JPMorgan Chase & Co. post first-quarter earnings reports.

In the high-grade secondary market, trading volume fell to $17.73 billion on Wednesday, according to Trace. Secondary market volume totaled $19.19 billion on Tuesday and $14.67 billion on Monday.

CVS Health Corp.’s senior notes (Baa1/BBB+) that priced in a $40 billion nine-tranche transaction on March 6 to fund its acquisition of Aetna Inc. remain active in the secondary market. The notes traded mostly softer at the start of the session, a source said.

CVS Health’s 4.3% notes due March 25, 2028 traded over the morning at 100.81. The notes went out on Wednesday in the secondary market at 100.99.

The 10-year notes were sold in a $9 billion tranche at 98.594 to yield 4.475%, or a spread of Treasuries plus 160 basis points.

The company’s 5.05% notes due March 25, 2048 opened softer at 105.68 from 106.07 on Wednesday.

The Woonsocket, R.I.-based retail pharmacy chain and pharmacy benefits manager sold $8 billion of the bonds at 99.43 to yield 5.087%, or a Treasuries plus 195 bps spread.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.